Prominent Israeli technology

Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, headquartered in Israel. The company is best known for its leadership in the generics market and its development of innovative treatments for central nervous system (CNS) disorders and respiratory diseases. Its flagship product, Copaxone, revolutionized the treatment of multiple sclerosis, while newer products like Ajovy and Austedo continue to drive growth in the specialty segment. Teva operates an extensive global manufacturing and R&D network, providing essential medicines to millions of patients worldwide. The company is currently focused on its 'Pivot to Growth' strategy, emphasizing its innovative pipeline and biosimilars.